BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
The Force of Systems administration: Individual Examples of overcoming adversity - 2IDF Givati Brigade soldier arrested, charged in suspected Iran espionage
- 3Steven Spielberg's 'Disclosure Day' trailer drops: What we know about the alien movie
- 4Gaza humanitarian efforts reach key milestone as UNICEF vaccinates some 13,000 children
- 5Raw oysters linked to ongoing salmonella outbreak infecting 64 across 22 states: CDC
- $1,000 bribes, Mormon momfluencer mixers and making content to get plastic surgery: The wildest things I learned reporting my book
- Opening Monetary Information: Your Exhaustive Manual for Finding out about Individual budget
- The Best Computer games Ever
- Mobility exercises are an important part of fitness as we age. Here are some tips
- Russian billionaire says 12-hour days and 6-day workweeks could help save the economy
- Scientists train to dive beneath polar ice as climate change warms the Arctic and Antarctica
- Discovering a true sense of harmony: Contemplation and Care Practices
- FBI arrests Brian Cole Jr. in Jan. 6 pipe bomb investigation, ending 5-year hunt
- Moon memorial: Artemis 2 astronauts name lunar 'bright spot' after mission commander's late wife
